A Phase II trial of topotecan and gemcitabine in patients with previously treated, advanced nonsmall cell lung carcinoma

David Rinaldi, Nancy A. Lormand, Joseph E. Brierre, James L. Cole, Brian C. Barnes, G. Percival Mills, Siva Yadlapati, M. Felicia Fontenot, Eric J. Buller, John M. Rainey

Cancer · 2002 · 20 citations · 18 references

DOIFull text

Open access

Abstract

The combination of topotecan and gemcitabine demonstrated antitumor activity with a modest side effect profile in patients with advanced, previously treated NSCLC.

References

18